| Literature DB >> 22684082 |
Kathrin Zuberbühler1, Giulio Casi, Gonçalo J L Bernardes, Dario Neri.
Abstract
We describe a method that enables specific and efficient conjugation of hydrazide-moieties to an IgG targeting the tumor neovasculature. The resulting chemically defined, homogeneous hydrazone-linked IgG conjugates remain immunoreactive and have a half-life of approximately 18 hours at physiological pH and temperature suitable for localized delivery of toxic drugs.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22684082 DOI: 10.1039/c2cc32412a
Source DB: PubMed Journal: Chem Commun (Camb) ISSN: 1359-7345 Impact factor: 6.222